Novo Nordisk

New Framework for Corporate Reporting to Integrate Sustainability and Financial Data

Investors and companies can give feedback on the International Integrated Reporting Framework, which will standardize the integration of sustainability perfo

Treating the Indonesian Diabetes Pandemic: A Case Study from Novo Nordisk

Danish pharmaceutical company Novo Nordisk has released a new case study that examines the challenges for diabetes care in Indonesia. The study reflects the company's work to provide diabetes care across Indonesia, a country where millions of people have diabetes but less than one per cent receives proper treatment.

Big Pharma Improves Access to Medicine in Developing World

The Access to Medicine Foundation has released its 2012 Access to Medic Index (ATM Index). The ATM Index is designed to provide independent, unbiased and credible information regarding individual pharmaceutical companies' progress on making drugs and other medical products more available and affordable in developing countries.

Socially Responsible Campaign Targets African Children With Type 1 Diabetes

Novo Nordisk is looking to increase access to education and treatment for children with type 1 diabetes in Africa.

Novo Nordisk Launches ‘Blueprint for Change’ Case on Bangladesh

Novo Nordisk made available the fourth case of its Blueprint for Change series, which focuses on Bangladesh.

Novo Nordisk Wins Best Sustainability Performance at 2012 Social Innovation Awards

The Danish healthcare firm continues its march to sustainability, collecting another honor along the way

BASF Sets High Standards for CSR Reporting in Germany

BASF Corporation, one of Europe’s leading CSR lights, recently published their latest integrated annual report.

Subscribe to Novo Nordisk